GlassScriptPhysician profile
Amanpreet Kaur
NPI 1225175748
$818.02
in general payments reported to CMS, 2019-2025
9 companies · $305 in 2025
The $305 reported for 2025 was more than what 84% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.91 · 2020: $12.04 · 2021: $92.62 · 2022: $14.09 · 2023: $207 · 2024: $147 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $387.94 | 2023-2025 | Invisalign, Invisalign System - Moderate |
| Solventum Corporation | $112.76 | 2024-2025 | 3m Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Scotchbond |
| 3m Company | $62.24 | 2021-2023 | 3m, Clarity Aligners |
| Dentsply Sirona INC | $58.41 | 2020-2021 | |
| Straumann USA LLC | $56.12 | 2023 | |
| Nobel Biocare USA | $47.71 | 2023 | Nobelactive |
| Voco America INC. | $38.62 | 2022-2023 | Admira Fusion X-Base, Admira Protect, Admira Fusion X-Tra |
| Orapharma, A Division of Bausch Health US, LLC | $28.15 | 2019-2025 | Ossix Plus, Arestin |
| Implant Direct Sybron International LLC | $26.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanpreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.